<DOC>
	<DOCNO>NCT00178594</DOCNO>
	<brief_summary>The objective study ass coagulation system in-vitro variety bleed clot disorder use ROTEG analyzer thrombin generation assay .</brief_summary>
	<brief_title>Evaluation Hemostasis Bleeding Thrombotic Disorders</brief_title>
	<detailed_description>This exploratory study involve blood coagulation assay select group individual . The ROTEG newly develop coagulation analyzer allow continuous assessment whole blood coagulation formation first fibrin fiber activate platelet , formation three-dimensional whole blood clot eventual dissolution clot . This device use diagnostic procedure tool . No recommendation regard interpretation result implication future treatment provide .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Blood Coagulation Disorders , Inherited</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Congenital Acquired Bleeding Disorder Congenital Acquired Thrombotic Disorder Poor venous access</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>98 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Hereditary Bleeding disorder</keyword>
	<keyword>Thrombotic Disorder</keyword>
</DOC>